Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

11.41
-0.1900-1.64%
Pre-market: 11.40-0.0100-0.09%05:57 EDT
Volume:115.71K
Turnover:1.34M
Market Cap:150.07M
PE:-1.90
High:12.11
Open:11.84
Low:11.26
Close:11.60
52wk High:16.00
52wk Low:3.39
Shares:13.15M
Float Shares:6.13M
Volume Ratio:0.42
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0077
EPS(LYR):-7.9367
ROE:-90.25%
ROA:-32.01%
PB:1.44
PE(LYR):-1.44

Loading ...

Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Sep 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2024

Correspondence

Form CORRESP - Correspondence
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 30, 2024

Correspondence

Form CORRESP - Correspondence
Jul 16, 2024

Major Issues Report

Form 8-K - Current report